BioPharma Drug Approval

FDA Approves Amgen LUMAKRAS™

KRAS G12C, a Driver Mutation Found in About 13% of Patients With Non-Squamous Non-Small Cell Lung Cancer, is Now Actionable(1) Once-Daily Dosing of LUMAKR...

 May 30, 2021 | News

Gannex Received China IND Approval

Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of non-...

 May 28, 2021 | News

Moderna and South Korea Explore Collaboration on mRNA Vaccines

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced two Memoranda of Unde...

 May 24, 2021 | News

Antengene Announces the IND Approval for Eltanexor

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commerc...

 May 14, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close